Definium Therapeutics (DFTX) Research & Development (2021 - 2026)
Definium Therapeutics' Research & Development was $48.67 million in Q2 2026, up 63.3% from $29.81 million a year earlier and up 17.3% from the prior quarter.
Powered by 
Analysis
Definium Therapeutics (DFTX) Research & Development (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Definium Therapeutics' Research & Development was $154.68 million through Jun 30, 2026, up 67.9% year-over-year; for FY2025, it was $117.7 million, up 80.2% from FY2024.
- Research & Development has now increased for six consecutive years, with a five-year compound annual growth rate of 44.6% (FY2020 to FY2025).
- In earlier years, Research & Development was $65.3 million in FY2024 (+25.3%), $52.12 million in FY2023 (+44.1%), $36.17 million in FY2022 (+4.0%) and $34.79 million in FY2021 (+86.7%).
- The Q2 2026 figure marks the highest quarterly Research & Development in data going back to Q1 2021.
- Compared with a year earlier, Research & Development has increased for eight straight quarters, with growth averaging 74.6% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q2 2025 (growth of 103.5%); the worst was Q4 2022 (a decline of 18.9%).
- Per Business Quant data, DFTX's Research & Development in the three quarters before Q2 2026 was $41.48 million (Q1 2026), $33.56 million (Q4 2025) and $30.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Definium Therapeutics | 4.00 Bn | 4.00 Bn | - | 48.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.67 Mn |
| Mar 31, 2026 | 41.48 Mn |
| Dec 31, 2025 | 33.56 Mn |
| Sep 30, 2025 | 30.98 Mn |
| Jun 30, 2025 | 29.81 Mn |
| Mar 31, 2025 | 23.36 Mn |
| Dec 31, 2024 | 21.76 Mn |
| Sep 30, 2024 | 17.19 Mn |
| Jun 30, 2024 | 14.65 Mn |
| Mar 31, 2024 | 11.71 Mn |
| Dec 31, 2023 | 11.55 Mn |
| Sep 30, 2023 | 13.20 Mn |
| Jun 30, 2023 | 14.78 Mn |
| Mar 31, 2023 | 12.60 Mn |
| Dec 31, 2022 | 8.83 Mn |
| Sep 30, 2022 | 7.77 Mn |
| Jun 30, 2022 | 9.33 Mn |
| Mar 31, 2022 | 10.24 Mn |
| Dec 31, 2021 | 10.88 Mn |
| Sep 30, 2021 | 9.02 Mn |
API Access
Definium Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=DFTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();